ABEONA THERAPEUTICS INC. Research and Development Expense
ABEONA THERAPEUTICS INC. (ABEO) reported Research and Development Expense of $5.02 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-13
- ABEONA THERAPEUTICS INC. research and development expense for the quarter ending 2026-06-30 was $5.02M, a 15.51% decline year-over-year.
- ABEONA THERAPEUTICS INC. research and development expense for the quarter ending 2026-03-31 was $9.55M, a 3.88% decline year-over-year.
- ABEONA THERAPEUTICS INC. research and development expense for the quarter ending 2025-12-31 was $6.71M, a 25.37% decline year-over-year.
- ABEONA THERAPEUTICS INC. research and development expense for the quarter ending 2025-09-30 was $4.22M, a 52.85% decline year-over-year.
- ABEONA THERAPEUTICS INC. research and development expense for fiscal 2025 was $26.81M, a 21.97% decline from fiscal 2024.
- ABEONA THERAPEUTICS INC. research and development expense for fiscal 2024 was $34.36M, a 10.51% increase from fiscal 2023.
- ABEONA THERAPEUTICS INC. research and development expense for fiscal 2023 was $31.09M, a 7.34% increase from fiscal 2022.
- ABEONA THERAPEUTICS INC. research and development expense for fiscal 2022 was $28.96M, a 25.21% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $5.02M 10-Q · filed 2026-08-13 | $14.58M 10-Q · filed 2026-08-13 | $21.29M derived: sum of 3 quarters · filed 2026-08-13 | $25.50M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $9.55M 10-Q · filed 2026-05-13 | $16.27M derived: sum of 2 quarters · filed 2026-05-13 | $20.48M derived: sum of 3 quarters · filed 2026-05-13 | $26.43M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $6.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $10.93M derived: sum of 2 quarters · filed 2026-03-17 | $16.87M derived: sum of 3 quarters · filed 2026-08-13 | $26.81M 10-K · filed 2026-03-17 | ||||
| 2025-09-30 | $4.22M 10-Q · filed 2025-11-12 | $10.16M derived: sum of 2 quarters · filed 2026-08-13 | $20.10M 10-Q · filed 2025-11-12 | $29.09M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $5.94M 10-Q · filed 2026-08-13 | $15.88M 10-Q · filed 2026-08-13 | $24.88M derived: sum of 3 quarters · filed 2026-08-13 | $33.82M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $9.94M 10-Q · filed 2026-05-13 | $18.93M derived: sum of 2 quarters · filed 2026-05-13 | $27.88M derived: sum of 3 quarters · filed 2026-05-13 | $37.09M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $8.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $17.93M derived: sum of 2 quarters · filed 2026-03-17 | $27.15M derived: sum of 3 quarters · filed 2026-03-17 | $34.36M 10-K · filed 2026-03-17 | ||||
| 2024-09-30 | $8.94M 10-Q · filed 2025-11-12 | $18.16M derived: sum of 2 quarters · filed 2025-11-12 | $25.37M 10-Q · filed 2025-11-12 | $32.74M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $9.22M 10-Q · filed 2025-08-14 | $16.43M 10-Q · filed 2025-08-14 | $23.80M derived: sum of 3 quarters · filed 2025-08-14 | $30.95M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $7.21M 10-Q · filed 2025-05-15 | $14.59M derived: sum of 2 quarters · filed 2025-05-15 | $21.73M derived: sum of 3 quarters · filed 2025-05-15 | $30.26M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $7.38M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $14.53M derived: sum of 2 quarters · filed 2025-03-20 | $23.05M derived: sum of 3 quarters · filed 2025-03-20 | $31.09M 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | $7.15M 10-Q · filed 2024-11-14 | $15.67M derived: sum of 2 quarters · filed 2024-11-14 | $23.71M 10-Q · filed 2024-11-14 | $29.98M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $8.52M 10-Q · filed 2024-08-12 | $16.56M 10-Q · filed 2024-08-12 | $22.84M derived: sum of 3 quarters · filed 2024-08-12 | $28.33M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | $8.04M 10-Q · filed 2024-05-15 | $14.31M derived: sum of 2 quarters · filed 2024-05-15 | $19.80M derived: sum of 3 quarters · filed 2024-05-15 | $26.46M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $6.27M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $11.76M derived: sum of 2 quarters · filed 2024-03-18 | $18.42M derived: sum of 3 quarters · filed 2024-03-18 | $28.96M 10-K · filed 2024-03-18 | ||||
| 2022-09-30 | $5.49M 10-Q · filed 2023-11-13 | $12.15M derived: sum of 2 quarters · filed 2023-11-13 | $22.69M 10-Q · filed 2023-11-13 | $35.50M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $6.66M 10-Q · filed 2023-08-08 | $17.20M 10-Q · filed 2023-08-08 | $30.01M derived: sum of 3 quarters · filed 2023-08-08 | $39.06M derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-03-31 | $10.54M 10-Q · filed 2023-05-11 | $23.35M derived: sum of 2 quarters · filed 2023-05-11 | $32.40M derived: sum of 3 quarters · filed 2023-05-11 | $40.94M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $12.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $21.86M derived: sum of 2 quarters · filed 2023-03-29 | $30.39M derived: sum of 3 quarters · filed 2023-03-29 | $38.73M 10-K · filed 2023-03-29 | $34.33M 10-K · filed 2022-03-31 | |||
| 2021-09-30 | $9.06M 10-Q · filed 2022-11-14 | $7.98M 10-Q · filed 2021-11-15 | $17.59M derived: sum of 2 quarters · filed 2022-11-14 | $25.92M 10-Q · filed 2022-11-14 | $22.62M 10-Q · filed 2021-11-15 | $35.15M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $8.53M 10-Q · filed 2022-08-11 | $7.43M 10-Q · filed 2021-07-28 | $16.87M 10-Q · filed 2022-08-11 | $14.65M 10-Q · filed 2021-07-28 | $26.09M derived: sum of 3 quarters · filed 2022-08-11 | $34.06M derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | $8.32M 10-Q · filed 2022-05-13 | $7.21M 10-Q · filed 2021-05-17 | $17.56M derived: sum of 2 quarters · filed 2022-05-13 | $25.53M derived: sum of 3 quarters · filed 2022-05-13 | $31.64M derived: sum of 4 quarters · filed 2022-05-13 | |||
| 2020-12-31 | $9.24M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $17.21M derived: sum of 2 quarters · filed 2022-03-31 | $23.32M derived: sum of 3 quarters · filed 2022-03-31 | $30.14M 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | $7.97M 10-Q · filed 2021-11-15 | $14.08M derived: sum of 2 quarters · filed 2021-11-15 | $20.90M 10-Q · filed 2021-11-15 | $30.50M derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | $6.11M 10-Q · filed 2021-07-28 | $12.93M 10-Q · filed 2021-07-28 | $22.53M derived: sum of 3 quarters · filed 2021-07-28 | $33.45M derived: sum of 4 quarters · filed 2021-07-28 | ||||
| 2020-03-31 | $6.82M 10-Q · filed 2021-05-17 | $16.42M derived: sum of 2 quarters · filed 2021-05-17 | $27.34M derived: sum of 3 quarters · filed 2021-05-17 | $43.65M derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | $9.61M 10-K · filed 2020-03-16 | $20.52M derived: sum of 2 quarters · filed 2020-11-09 | $36.83M derived: sum of 3 quarters · filed 2020-11-09 | $48.57M 10-K · filed 2021-03-24 | ||||
| 2019-09-30 | $10.92M 10-Q · filed 2020-11-09 | $27.22M derived: sum of 2 quarters · filed 2020-11-09 | $38.96M 10-Q · filed 2020-11-09 | $48.43M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | $16.31M 10-Q · filed 2020-08-10 | $28.04M 10-Q · filed 2020-08-10 | $37.51M derived: sum of 3 quarters · filed 2020-08-10 | $50.66M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | $11.74M 10-Q · filed 2020-05-06 | $21.21M derived: sum of 2 quarters · filed 2020-05-06 | $34.36M derived: sum of 3 quarters · filed 2020-05-06 | $42.27M derived: sum of 4 quarters · filed 2020-05-06 | ||||
| 2018-12-31 | $9.47M 10-K · filed 2020-03-16 | $22.62M derived: sum of 2 quarters · filed 2020-03-16 | $30.54M derived: sum of 3 quarters · filed 2020-03-16 | $38.70M 10-K · filed 2020-03-16 | ||||
| 2018-09-30 | $13.15M 10-K · filed 2020-03-16 | $21.07M derived: sum of 2 quarters · filed 2020-03-16 | $29.23M 10-Q · filed 2019-11-12 | $34.93M derived: sum of 4 quarters · filed 2020-03-16 | ||||
| 2018-06-30 | $7.92M 10-K · filed 2020-03-16 | $16.08M 10-Q · filed 2019-08-09 | $21.78M derived: sum of 3 quarters · filed 2020-03-16 | $25.06M derived: sum of 4 quarters · filed 2020-03-16 | ||||
| 2018-03-31 | $8.16M 10-K · filed 2020-03-16 | $13.87M derived: sum of 2 quarters · filed 2020-03-16 | $17.14M derived: sum of 3 quarters · filed 2020-03-16 | $22.95M derived: sum of 4 quarters · filed 2020-03-16 | ||||
| 2017-12-31 | $5.71M 10-K · filed 2019-03-18 | $8.98M derived: sum of 2 quarters · filed 2019-03-18 | $14.79M derived: sum of 3 quarters · filed 2019-03-18 | $16.99M 10-K · filed 2020-03-16 | ||||
| 2017-09-30 | $3.28M 10-K · filed 2019-03-18 | $9.09M derived: sum of 2 quarters · filed 2019-03-18 | $11.28M 10-Q · filed 2018-11-09 | $14.32M derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2017-06-30 | $5.81M 10-K · filed 2019-03-18 | $8.01M 10-Q · filed 2018-08-09 | $11.04M derived: sum of 3 quarters · filed 2019-03-18 | $13.79M derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2017-03-31 | $2.20M 10-K · filed 2019-03-18 | $5.24M derived: sum of 2 quarters · filed 2019-03-18 | $7.98M derived: sum of 3 quarters · filed 2019-03-18 | $11.00M derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2016-12-31 | $3.04M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $5.78M derived: sum of 2 quarters · filed 2019-03-18 | $8.80M derived: sum of 3 quarters · filed 2019-03-18 | $10.65M 10-K · filed 2019-03-18 | ||||
| 2016-09-30 | $2.75M 10-Q · filed 2017-11-14 | $5.76M derived: sum of 2 quarters · filed 2017-11-14 | $7.62M 10-Q · filed 2017-11-14 | $9.69M derived: sum of 4 quarters · filed 2017-11-14 | ||||
| 2016-06-30 | $3.02M 10-Q · filed 2017-08-14 | $4.87M 10-Q · filed 2017-08-14 | $6.94M derived: sum of 3 quarters · filed 2017-08-14 | $8.53M derived: sum of 4 quarters · filed 2017-08-14 | ||||
| 2016-03-31 | $1.85M 10-Q · filed 2017-05-15 | $3.93M derived: sum of 2 quarters · filed 2017-05-15 | $5.51M derived: sum of 3 quarters · filed 2017-05-15 | $6.12M derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | $2.07M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $3.65M derived: sum of 2 quarters · filed 2017-03-30 | $4.26M derived: sum of 3 quarters · filed 2017-03-30 | $4.71M 10-K · filed 2017-03-30 | ||||
| 2015-09-30 | $1.58M 10-Q · filed 2016-11-14 | $2.19M derived: sum of 2 quarters · filed 2016-11-14 | $2.64M 10-Q · filed 2016-11-14 | $2.68M derived: sum of 4 quarters · filed 2016-11-14 | ||||
| 2015-06-30 | $610.00K 10-Q · filed 2016-08-15 | $1.06M 10-Q · filed 2016-08-15 | $1.10M derived: sum of 3 quarters · filed 2016-08-15 | $1.17M derived: sum of 4 quarters · filed 2016-08-15 | ||||
| 2015-03-31 | $453.00K 10-Q · filed 2016-05-16 | $488.00K derived: sum of 2 quarters · filed 2016-05-16 | $561.00K derived: sum of 3 quarters · filed 2016-05-16 | $642.00K derived: sum of 4 quarters · filed 2016-05-16 | ||||
| 2014-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $108.00K derived: sum of 2 quarters · filed 2016-03-30 | $189.00K derived: sum of 3 quarters · filed 2016-03-30 | $333.00K 10-K · filed 2016-03-30 | ||||
| 2014-09-30 | $73.00K 10-Q · filed 2015-11-16 | $154.00K derived: sum of 2 quarters · filed 2015-11-16 | $298.00K 10-Q · filed 2015-11-16 | $426.00K derived: sum of 4 quarters · filed 2015-11-16 | ||||
| 2014-06-30 | $81.00K 10-Q · filed 2015-08-14 | $225.00K 10-Q · filed 2015-08-14 | $353.00K derived: sum of 3 quarters · filed 2015-08-14 | $589.00K derived: sum of 4 quarters · filed 2015-08-14 | ||||
| 2014-03-31 | $144.00K 10-Q · filed 2015-05-14 | $72.00K 10-Q · filed 2014-05-12 | $272.00K derived: sum of 2 quarters · filed 2015-05-14 | $508.00K derived: sum of 3 quarters · filed 2015-05-14 | $705.00K derived: sum of 4 quarters · filed 2015-05-14 | |||
| 2013-12-31 | $128.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $364.00K derived: sum of 2 quarters · filed 2015-03-31 | $561.00K derived: sum of 3 quarters · filed 2015-03-31 | $884.00K 10-K · filed 2015-03-31 | ||||
| 2013-09-30 | $236.00K 10-Q · filed 2014-11-14 | $433.00K derived: sum of 2 quarters · filed 2014-11-14 | $756.00K 10-Q · filed 2014-11-14 | $1.05M derived: sum of 4 quarters · filed 2014-11-14 | ||||
| 2013-06-30 | $197.00K 10-Q · filed 2014-08-14 | $520.00K 10-Q · filed 2014-08-14 | $818.00K derived: sum of 3 quarters · filed 2014-08-14 | $1.13M derived: sum of 4 quarters · filed 2014-08-14 | ||||
| 2013-03-31 | $323.00K 10-Q · filed 2014-05-12 | $621.00K derived: sum of 2 quarters · filed 2014-05-12 | $929.00K derived: sum of 3 quarters · filed 2014-05-12 | $1.58M derived: sum of 4 quarters · filed 2014-05-12 | ||||
| 2012-12-31 | $298.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $606.00K derived: sum of 2 quarters · filed 2014-03-26 | $1.26M derived: sum of 3 quarters · filed 2014-03-26 | $2.01M 10-K · filed 2014-03-26 | ||||
| 2012-09-30 | $308.00K 10-Q · filed 2013-11-14 | $962.00K derived: sum of 2 quarters · filed 2013-11-14 | $1.71M 10-Q · filed 2013-11-14 | $2.47M derived: sum of 4 quarters · filed 2013-11-14 | ||||
| 2012-06-30 | $654.00K 10-Q · filed 2013-08-14 | $1.40M 10-Q · filed 2013-08-14 | $2.16M derived: sum of 3 quarters · filed 2013-08-14 | $3.07M derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2012-03-31 | $750.00K 10-Q · filed 2013-05-15 | $974.00K 10-Q · filed 2012-05-15 | $1.51M derived: sum of 2 quarters · filed 2013-05-15 | $2.41M derived: sum of 3 quarters · filed 2013-05-15 | $3.32M derived: sum of 4 quarters · filed 2013-05-15 | |||
| 2011-12-31 | $757.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-20 | $1.66M derived: sum of 2 quarters · filed 2013-03-20 | $2.57M derived: sum of 3 quarters · filed 2013-03-20 | $3.58M 10-K · filed 2013-03-20 | $4.20M 10-K · filed 2012-03-23 | |||
| 2011-09-30 | $906.00K 10-Q · filed 2012-11-14 | $1.06M 10-Q · filed 2011-11-14 | $1.81M derived: sum of 2 quarters · filed 2012-11-14 | $2.82M 10-Q · filed 2012-11-14 | $3.24M 10-Q · filed 2011-11-14 | $3.56M derived: sum of 4 quarters · filed 2012-11-14 | ||
| 2011-06-30 | $1.06M 10-Q · filed 2011-08-15 | $1.92M 10-Q · filed 2012-08-14 | $2.18M 10-Q · filed 2011-08-15 | $2.65M derived: sum of 3 quarters · filed 2012-08-14 | $3.85M derived: sum of 4 quarters · filed 2012-08-14 | |||
| 2011-03-31 | $1.12M 10-Q · filed 2012-05-15 | $1.75M derived: sum of 2 quarters · filed 2012-05-15 | $2.95M derived: sum of 3 quarters · filed 2012-05-15 | $3.68M derived: sum of 4 quarters · filed 2012-05-15 | ||||
| 2010-12-31 | $631.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-23 | $1.83M derived: sum of 2 quarters · filed 2012-03-23 | $2.56M derived: sum of 3 quarters · filed 2012-03-23 | $3.35M 10-K · filed 2012-03-23 | ||||
| 2010-09-30 | $1.20M 10-Q · filed 2011-11-14 | $1.93M derived: sum of 2 quarters · filed 2011-11-14 | $2.72M 10-Q · filed 2011-11-14 | |||||
| 2010-06-30 | $733.00K 10-Q · filed 2011-08-15 | $1.52M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |